Identifying Good Responders to Glucose Lowering Therapy in Type 2 Diabetes: Implications for Stratified Medicine

Open Access

Peer-reviewed

Research Article

Angus G. Jones ,

* E-mail: angus.jones@exeter.ac.uk

Affiliation NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, United Kingdom
⨯
Beverley M. Shields,

Affiliation NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, United Kingdom
⨯
Christopher J. Hyde,

Affiliation Public Health and Epidemiology, University of Exeter Medical School, Exeter, United Kingdom
⨯
William E. Henley,

Affiliation Institute of Health Research, University of Exeter Medical School, Exeter, United Kingdom
⨯
Andrew T. Hattersley

Affiliation NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, United Kingdom
⨯

Reader Comments (0)

HbA1c
Is the Subject Area "HbA1c" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Linear regression analysis
Is the Subject Area "Linear regression analysis" applicable to this article?

Thanks for your feedback.
Creatinine
Is the Subject Area "Creatinine" applicable to this article?

Thanks for your feedback.
Diabetes diagnosis and management
Is the Subject Area "Diabetes diagnosis and management" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.